ISGE 2016 — Announcing

 

isge2016_testatina_mail

Scientific Program

Opening Lectures

  • THE ROLE OF KIS PEPTIDES IN THE REGULATION OF THE OVULATORY CYCLE

    • Lunenfeld Bruno (IL) The role of kis peptides in the regulation of the ovulatory cycle

     

Plenary Lectures

  • (PL01) HUMAN UTERUS TRANSPLANTATION WITH LIVEBIRTHS

    • Braennstroem Mats (SE) Human uterus transplantation with livebirths
  • (PL02) PERSONALIZED MEDICINE FOR MENOPAUSE: WHERE ARE WE IN 2016?

    • Santen Richard J. (US) Personalized medicine for menopause: where are we in 2016?
  • (PL03) ANOREXIA NERVOSA: NEW DEVELOPMENTS IN ENDOCRINOLOGY AND METABOLISM

    • Sultan Charles (FR) Anorexia nervosa: new developments in endocrinology and metabolism
  • (PL04) FROM CORTISOL TO ESTRADIOL AND PROGESTERONE: CAN WE EFFECTIVELY MANIPULATE TISSUE CONTENT OF STEROIDS?

    • Bouchard Phillipe (FR) From cortisol to estradiol and progesterone: can we effectively manipulate tissue content of steroids?

Plenary Sessions

  • (PS01) NEW INSIGHT INTO FEMALE- SPECIFIC FACTOR THAT INFLUENCE BRAIN FUNCTION

    • Maki Pauline (US) The link between vasomotor symptoms and memory decline: how strong is the evidence?
    • Schagen Sanne (NL) Cognition and brain function and structure in breast cancer survivors: effects of systemic therapy
    • Hunter Myra (GB) Cognitive behavior therapy as a treatment for VMS: evidence from RCTs and mechanism of action
  • (PS02) NEUROENDOCRINOLOGY : FROM BASIC SCIENCE TO CLINICAL IMPACT

    • Naftolin Frederick (US) Creating positive feedback in organ culture of the rat hypothalamus
    • Bouchard Phillipe (FR) Hypogonadotropic hypogonadisms etiologies and applications
    • Berga Sarah (US) The neuroendocrine impact of cognitive behavior therapy of stress-induced anovulation
    • Maki Pauline (US) Stress responsivity in midlife women: the role of childhood trauma
  • (PS03) BREAST CANCER RISK AND HORMONES -part 1-

    • Kiesel Ludwig (DE) Progestins and breast carcinogenesis
    • Ruan Xiangyan (CN) Dependency on dosage, duration, regimen and type?
    • Biglia Nicoletta (IT) Risk of breast cancer following fertility treatments
    • Santen Richard J. (US) Can therapies for menopausal symptoms prevent breast cancer at the same time?
  • (PS04) BREAST CANCER RISK AND HORMONES -part 2-

    • Mueck Alfred (DE) Preconditions of genotoxic estrogen metabolites to induce breast cancer
    • Sismondi Piero (IT) Obesity, inflammation and breast cancer
    • von Schoultz Bo (SE) Are androgens risk factors or protective for the breast?
    • Foidart Jean Michel (BE) Endocrine sensitivity of normal and malignant breast: a concern?
  • (PS05) METABOLIC SYNDROME

    • Berga Sarah (US) Stress, emotional eating, and reproduction: role of GABA
    • Genazzani Alessandro D. (IT) Insulin resistance, PCOS and obesity: integrative treatments that can improve insulin sensitivity
    • Chedraui Peter (EC) The metabolic syndrome after the menopause: pro-inflammation and endothelial dysfunction
    • Perez-Lopez Faustino (ES) Insulin resistance and endometrial cancer
  • (PS06) SPORT AND FEMALE REPRODUCTIVE FUNCTION

    • Paoletti Anna Maria (IT) Thinness and physical activity
    • Sultan Charles (FR) Female athletes and bone mass acquisition: a paradox ?
    • Hirschberg Angelica L. (SE) Hyperandrogenism and PCOS in female athletes: an advantage for physical performance?
  • (PS07) PCOS

    • Milewicz Andrzej (PL) Serum glipikan 4 levels in women with pcos
    • Fauser Bart C. (NL) PCOS: reproductive dysfunction and long-term cardiovascular health implications
    • Tarlatzis Basil (GR) Can we eliminate OHSS in PCOS women undergoing ovarian stimulation for IVF ?
    • Perez-Lopez Faustino (ES) Obesity and metabolic syndrome in adolescents
  • (PS08) SEXUALITY

    • Castelo Branco Camil (ES) Sexuality and quality of life in congenital hypogonadisms
    • Hirschberg Angelica L. (SE) Influence of oral contraceptives on sexuality: evidence from randomized
      placebo-controlled trials
    • Bitzer Johannes (CH) Sexual pain: how to manage ?
    • Nappi Rossella (IT) Is a sexy life an healthy life at menopause?
  • (PS09) PREGNANCY AND PROGESTERONE

    • Devoto Luigi (CL) Progesterone from ovulation to pregnancy
    • Petraglia Felice (IT) Pregnancy at risk in women with reproductive disorders
    • Schindler Adolf (DE) Type of progestogen used for treatment and prevention of pregnancy disorders and mechanisms of action
    • Carp Howard (IL) Results of recent meta-analyses on progestogens in threatened and recurrent miscarriage
  • (PS10) HRT AND CARDIOVASCULAR RISK

    • Lambrinoudaki Irene (GR) Managing cardio-metabolic risk after menopause
    • Collins Peter (GB) Management of coronary disease in postmenopausal women
    • Siseles Nestor (AR) Cardiovascular health in menopausal woman : when to begin the hormone treatment ?
    • Birkhaeuser Martin (CH) Why prefer transdermal to oral menopausal hormone therapy
  • (PS11) NEUROSTEROIDS : THE BRAIN AS A TARGET

    • Sitruk – Ware Regine (US) Progesterone and the brain
    • Schumacher Michael (FR) Androgen and the brain
    • Genazzani Andrea R. (IT) Estrogens and the brain
  • (PS12) ATHEROSCLEROSIS IN WOMEN

    • Stevenson John C. (GB) Assessment of cardiovascular risk at the menopause
    • Arnal Jean Francois (FR) Understanding the tissue specific action of estrogens and selective estrogen receptor modulators
    • Simoncini Tommaso (IT) Role of progesterone and progestins on endothelial coagulation and fibrinolytic
      pathways
  • (PS13) IVF : FROM THE PATIENTS TO THE CLINIC

    • Artini Paolo G. (IT) Gene expression in cumulus cells and IVF outcome
    • Gianaroli Luca (IT) NGP: new generation patients
    • Barri Pedro N. (ES) PGS in IVF implantation failure
    • Donnez Jaques (BE) Should we treat myomas before IVF ? If yes ,which treatment ?
  • (PS14) IVF : THE THERAPIES

    • La Marca Antonio (IT) How to choose the FSH starting dose in IVF
    • Imthurn Bruno (CH) Clinical and patient experience with a novel r-hFSH in IVF
    • Shoham Zeev (IL) How aggressive we needs to be with luteal phase support? Progesterone, Estrogen, GnRH agonist, or hCG
    • Lunenfeld Bruno (IL) Towards a hyperstimulation free clinic
  • (PS15) VITAMIN D AND BONE METABOLISM

    • Milewicz Andrzej (PL) Vitamin D , Vitamine D Binding Proteine and VDR gene polymorphisms in women PCOS
    • Brincat Mark (MT) A new look at Vitamin D and its pharmacological application in infertility
    • Al-Azzawi Farook (GB) The clinical choice between oestrogen and bisphosphonates in the prevention of post-menopausal osteoporosis – are women being mislead ?
    • Palacios Santiago (ES) New strategies in the treatment of osteoporosis
  • (PS16) RECONSTRUCTIVE SURGERY

    • Creatsas George (GR) Vulvovaginal congenital anomalies
    • Fedele Luigi (IT) Creation of a neovagina by Davydov’s laparoscopic modified technique in patients with
      Rokitansky syndrome
    • Adamyan Leila (RU) Uptodate strategy for myoma, endometriosis and adenomyosis
    • Mettler Liselotte (DE) When is tubectomy and when ovariectomy indicated in benign gynecological surgery
  • (PS17) HIGH RISK PREGNANCY

    • Holzgreve Wolfgang (DE) Non-invasive prenatal diagnostics from material blood – finally available in clinical practice
    • Hod Moshe (IL) Towards a universal consensus on diagnosis of GDM – The FIGO GDM initiative project
    • Ferrazzi Enrico M. (IT) Clinical phenotypes of pre-eclampsia
    • Di Renzo Gian Carlo (IT) Prevention and management for postpartum hemorrhage in anomalies of placenta insertion
  • (PS18) OVARIAN CANCER AND ANDROGENS SECRETING

    • Kenemans Peter (NL) Ovarian carcinoma in BRCA mutation carriers
    • Benedetti Panici Pierluigi (IT) Conservative Surgery for the Treatment for Epitelial Ovarian Cancer
    • Gadducci Angiolo (IT) Parp inhibitors in ovarian cancer
    • Noelting Manuel (AR) Androgens secreting tumors
  • (PS19) DUB AND FIBROIDS

    • Goldstein Steven R. (US) Diagnosis of DUB: the standard of care has changed!
    • Lumsden Mary Ann (GB) Studies of the mechanism of action of UAE
    • Maruo Takeshi (JP) Lessons learned from the preclinical studies with PRMs for non-surgical treatment of
      uterine fibroids
    • Sciarra John J. (US) New management for uterine fibroids
  • (PS20) CLINICAL TRIALS IN MENOPAUSE

    • Naftolin Frederick (US) An update of studies on HRT since the WHI
    • Schierbeck Louise (DK) Cardiovascular disease in postmenopausal women; does HRT have a role?
    • Canonico Marianne (FR) HRT and venous thromboembolism … what differences between US and South European treatments ?
    • Gompel Anne (FR) Progestins and breast cancer Risk highlights from France ?
  • (PS21) MENOPAUSE AND PERSONAL RISKS

    • Cano Antonio (ES) Personalised medicine after menopause: the case of women with profiles of risk
    • De Geyter Christian (CH) Effects of HRT on gene expression in breast tissue of healthy postmenopausal women
    • Brincat Mark (MT) Muscolo skeletal changes in the menopause and their response to HRT
    • Studd John (GB) Hormone therapy for depression and loss of libido
  • (PS22) HYPOGONADISM AND POF

    • Panay Nicholas (GB) POI registry: new frontiers in global collaboration
    • Ben Rafael Zion (IL) Poor ovarian reserve- what can be done?
    • Meczekalski Blazej (PL) Long-term consequences of POF
    • Vujovic Svetlana (RS) Premature Ovarian Failure, Transsexualism: evolutionary concept
  • (PS23) CONTRACEPTION : FROM NEEDS TO POSSIBILITIES

    • De Melo Nilson R. (BR) Contraception in special situations
    • Schindler Adolf (DE) Progestogen-only contraceptives: benefits and risks
    • Sitruk – Ware Regine (US) Progesterone receptor modulators for contraception
    • Nappi Rossella (IT) Pain threshold modulation by CHC in women with menstrually-related migraine
  • (PS24) FERTILITY PRESERVATION

    • Fauser Bart C. (NL) Fertility preservation: How to balance potential benefits versus risks
    • Anderson Richard A. (GB) Personalising decision making in fertility preservation
    • Donnez Jaques (BE) Restoration of ovarian activity and fertility after ovarian tissue transplantion
    • Benedetto Chiara (IT) Pregnancy outcomes after autologous ovarian transplantation

Meet the Experts

  • (ME01) ENDOMETRIUM

    • Simon Carlos (ES) Scratch or not to Scratch?
    • Goldstein Steven R. (US) Modern evaluation of the endometrium
  • (ME02) ENDOMETRIOSIS

    • Petraglia Felice (IT) Mechanisms of action of medical treatments
    • Kiesel Ludwig (DE) When and how to treat deep-infiltrating endometriosis prior to IVF
  • (ME03) STEM CELLS : FROM THE THERAPY TO THE PRACTICE

    • Simon Carlos (ES) Stem Cell Therapy of the Endometrium in Asherman´s syndrome and atrophic endometrium
    • Anderson Richard A. (GB) Ovarian Germline stem cells

http://agef.mailupclientab.com/frontend/nl_preview_window.aspx?idNL=754&fc=NzU0&source=SOCIAL

Конференции, Новости.